🔎 Trials Near Me

Akèy › Neoplazmi myeloproliferatif › Ohio › Cleveland

Etid klinik pou Neoplazmi myeloproliferatif nan Cleveland, OH

8 etid pou Neoplazmi myeloproliferatif ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Case Western Reserve University, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Case Western Reserve University, Cleveland
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Ap rekriteFaz 1/2
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT03471260

Project: Every Child for Younger Patients With Cancer

Ap rekriteEtid obsèvasyon
  • Rainbow Babies and Childrens Hospital, Cleveland
  • Cleveland Clinic Foundation, Cleveland
Jiska laj 25 · Tout sèks · Mizajou Aug 25, 2026 · NCT02402244

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06034002

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Etid Neoplazmi myeloproliferatif nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.